Helping people overcome breathlessness

Greenwich Hospital is seeking 10 to 14 men and women who suffer from chronic breathlessness to participate in a national medication study.

Professor Melanie Lovell, Staff Specialist in Palliative Medicine with HammondCare, said the large scale clinical study was designed to measure the benefits of using a regular low dose of morphine to relieve the symptoms of breathlessness.

“The trial is an opportunity for us to increase the evidence base around the benefits of the medication so it can be included as an option in the treatment of breathlessness,” Professor Lovell said.

“With this definitive study, we can do something about chronic breathlessness and significantly improve the quality of life for thousands of people.”

Participants must be over 18 and suffering from chronic obstructive pulmonary disease. More than 300,000 Australians are affected by chronic breathlessness with around 75,000 confined to their homes.

“Greenwich Hospital, along with a number of other hospitals in NSW, Victoria, South Australia, Queensland and Western Australia will be involved in the study which is being run by the Palliative Care Clinical Studies Collaborative (PaCCSC)” Professor Lovell said.

“The focus of the study, to help those people in need, aligns well with HammondCare’s mission and values.”

Anyone interested in participating in the trial is invited to contact Bronwyn Raymond, Clinical Trials Coordinator, HammondCare on 02 8788 3956.